Vincenzo LiCausi has been promoted to VP of finance of Cambridge Heart (Bedford, Massachusetts). LiCausi replaces Roderick de Greef, who earlier this year notified the company of his intention to resign. Prior to joining Cambridge Heart in October 2006, LiCausi worked for two years in the finance department at Bard Electrophysiology. Cambridge Heart makes products for the non-invasive diagnosis of cardiac disease, particularly the identification of those at risk of sudden cardiac arrest.

Jay Stoerker has been named VP of product development for SensiGen (Ann Arbor, Michigan). Stoerker most recently headed technology development at Matritech. SensiGen develops gene-based molecular diagnostics.

No Comments